IDIX
Idenix Pharmaceuticals Inc
Biopharmaceutical company developing antiviral treatments
CUSIP: 45166R204HealthcareUS1 holder
Total Value
$100.42M
Total Shares
20.70M
Net Share Change
+20.70M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$100.42M20.70M sharesNEW